SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-09-008857
Filing Date
2009-02-17
Accepted
2009-02-17 15:11:38
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND II, L.P.RA CAPITAL HEALTHCARE FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 v140198_sc13ga.htm SC 13G/A 152065
  Complete submission text file 0001144204-09-008857.txt   154051
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79091 | Film No.: 09611655
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199
Business Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199 617-778-2512
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A